Related Experiment Video
Updated: Aug 9, 2026
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Effects of iron therapy on infant blood lead levels
Abraham W Wolf1, Elias Jimenez, Betsy Lozoff
1Department of Psychiatry, MetroHealth Medical Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44109, USA. axw7@cwru.edu
Insights
Correcting iron deficiency in infants rapidly improves blood lead levels. Oral iron therapy was most effective, even in nonanemic infants, highlighting the link between iron status and lead absorption.
Area of Science:
- Pediatric Environmental Health
- Nutritional Science
- Toxicology
Background:
- Elevated blood lead levels (BLLs) in infants pose significant health risks.
- Iron deficiency is common in infants and may influence lead absorption.
- The interplay between iron status and BLLs requires further investigation.
Purpose of the Study:
- To investigate the impact of iron therapy on BLLs in infants with mild lead elevation.
- To examine how varied iron status affects the response to iron treatment regarding BLLs.
Main Methods:
- Community-derived sample of infants in Costa Rica.
- Categorization into five groups based on iron status and hemoglobin levels.
- Intervention groups received oral iron, intramuscular iron, or placebo for 3 months.
Main Results:
- Oral iron therapy significantly decreased BLLs in nonanemic iron-depleted and iron-deficient infants.
- Iron-deficient infants with hemoglobin <120 g/L showed decreased BLLs with oral iron but increased BLLs with intramuscular iron.
- BLLs increased in iron-sufficient infants receiving placebo.
Conclusions:
- Blood lead level changes correlate with iron status improvements.
- Iron absorption mechanisms likely explain the observed lead level fluctuations.
- Addressing iron deficiency is an effective strategy to reduce infant BLLs.
Objectives:
To determine the effects of iron therapy on blood lead levels in infants with mildly elevated lead levels and varied iron status.
Methods:
Infants from a community-derived sample in Costa Rica were categorized into five groups. Group 1 had iron-deficiency anemia with hemoglobin levels
Results:
After 3 months of oral iron therapy, nonanemic iron-depleted infants had the greatest decrease in lead levels, followed by nonanemic iron-deficient infants and iron-deficient infants with hemoglobin levels <120 g/L. Lead levels increased among iron-deficient infants with hemoglobin levels <120 g/L who received intramuscular iron and iron-sufficient nonanemic infants who received placebo.
Conclusions:
Changes in lead levels corresponded closely to changes in iron status and were plausible in terms of absorption mechanisms for lead and iron. Correcting and/or preventing iron deficiency appear to be rapid and effective means of improving infant lead levels, even in nonanemic infants.
More Related Videos
04:48Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry (CE-ICP-MS) for Quantification of Iron Redox Species (Fe(II), Fe(III))
Published on: May 4, 2020
08:45Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
